6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Latest Press Releases

Time	Headline
Just now	Quarterly Report and Appendix 5B
Just now	Mar26 Appendix 4C Cash Flow Report
Just now	Quarterly Activities Report and Appendix 4C - March 2026
47m ago	Fermi Inc. Appoints Rob L. Masson II as Interim Chief Financial Officer
47m ago	Neusoft Smart Go and Tencent Cloud Forge Strategic Partnership to Build a New AI-Powered Intelligent Cockpit Ecosystem

About

Swedish Orphan Biovitrum Ab — investor relations, events, news, and company updates on 6ix.

Latest News

Sobi Q1 2026 report: Strong execution and pipeline momentum

Sobi Receives Health Canada Approval for EMPAVELI® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN

Sobi publishes Annual and Sustainability Report for 2025

EMA validates indication extension application for Tryngolza® (olezarsen) for the treatment of severe hypertriglyceridemia (sHTG)

Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)

Recent Videos

Swedish Orphan Biovitrum Capital Market Day 2026 | Feb 18, 2026

Swedish Orphan Biovitrum Capital Market Day 2026 | Feb 18, 2026

Feb 22, 2026

Unite4Rare - Sobi’s long-standing commitment to the patient and caregiver community

Unite4Rare - Sobi’s long-standing commitment to the patient and caregiver community

Feb 18, 2026

Swedish Orphan Biovitrum Q4 2025 Earnings Call

Swedish Orphan Biovitrum Q4 2025 Earnings Call

Feb 09, 2026

TD Healthcare 2026-01-12 | Sobi, Astra Zeneca, Eli Lilly, Surgical Science, Revolution Medicines mfl

TD Healthcare 2026-01-12 | Sobi, Astra Zeneca, Eli Lilly, Surgical Science, Revolution Medicines mfl

Jan 12, 2026

Community Chat

Ask AI

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren